pyrrolidonecarboxylic acid and Angiogenesis, Pathologic

pyrrolidonecarboxylic acid has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gacs, A; Hegedüs, R; Kapuvári, B; Manea, M; Mező, G; Schulcz, Á; Tóvári, J; Vincze, B1
Baba, K; Kido, T; Kimura, Y; Sumiyoshi, M; Takaku, T1

Other Studies

2 other study(ies) available for pyrrolidonecarboxylic acid and Angiogenesis, Pathologic

ArticleYear
Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice.
    Investigational new drugs, 2016, Volume: 34, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Butyric Acid; Cell Proliferation; Colorectal Neoplasms; Daunorubicin; Female; Gonadotropin-Releasing Hormone; Heart; HT29 Cells; Humans; Liver; Male; Mice; Neovascularization, Pathologic; Pyrrolidonecarboxylic Acid; Tumor Burden; Xenograft Model Antitumor Assays

2016
Isolation of an anti-angiogenic substance from Agaricus blazei Murill: its antitumor and antimetastatic actions.
    Cancer science, 2004, Volume: 95, Issue:9

    Topics: Administration, Oral; Agaricus; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; CD8-Positive T-Lymphocytes; Collagen; Drug Combinations; Female; Killer Cells, Natural; Laminin; Lung Neoplasms; Lymphocyte Count; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Proteoglycans; Pyrrolidonecarboxylic Acid; Spleen; Vascular Endothelial Growth Factor A

2004